Oligarchy 发表于 2025-3-25 05:12:03

http://reply.papertrans.cn/1/9/831/831-21.png

秘方药 发表于 2025-3-25 11:15:59

http://reply.papertrans.cn/1/9/831/831-22.png

有特色 发表于 2025-3-25 13:44:01

Submitted on: 16 December 2009.
Revised on: 24 January 2010.
Accepted on: 25 February 2010.

___________________Advances in Urology---HINDAWI LTD

Ambulatory 发表于 2025-3-25 15:53:22

http://reply.papertrans.cn/1/9/831/831-24.png

Highbrow 发表于 2025-3-25 20:11:32

Submitted on: 23 May 2019.
Revised on: 07 July 2019.
Accepted on: 24 July 2019.

___________________Advances in Urology---HINDAWI LTD

CAMEO 发表于 2025-3-26 02:26:01

Submitted on: 25 October 1999.
Revised on: 21 February 2000.
Accepted on: 03 April 2000.

___________________Advances in Urology---HINDAWI LTD

中国纪念碑 发表于 2025-3-26 06:03:43

http://reply.papertrans.cn/1/9/831/831-27.png

Promotion 发表于 2025-3-26 11:30:22

Submitted on: 27 February 2010.
Revised on: 07 April 2010.
Accepted on: 21 April 2010.

___________________Advances in Urology---HINDAWI LTD

新娘 发表于 2025-3-26 14:59:44

http://reply.papertrans.cn/1/9/831/831-29.png

暴行 发表于 2025-3-26 20:42:02

http://reply.papertrans.cn/1/9/831/831-30.png
页: 1 2 [3] 4
查看完整版本: ESCI期刊Advances in Urology 2024/2025影响因子:1.832 (ADV UROL) (1687-6369). (UROLOGY & NEPHROLOGY)(泌尿学与肾脏病学)Emerging Sources